Figure 3: The interactions of best inhibitors-Charybdotoxin-C docked complexes and the potential energy profile of (a) Mephenytoin; (b) Phensuximide; (c) Primidone; (d) Valproate; (e) Ethosuximide; (f) Fosphenytoin (g) Lamotringine; (h) Carbamazepine